Clinical Trial Update: InductionChemo-Radio-Antibody-Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial of induction chemo-radiation-antibody therapy for squamous cell carcinoma of the head and neck has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Squamous Cell Carcinoma of the Head, Squamous Cell Carcinoma of the Neck | Phase 2 | Status: COMPLETED